Cannabis adulterated with the synthetic cannabinoid receptor agonist MDMB-4en-Pinaca and the role of European drug checking services

Bibliographic Data

ID14909159
AuthorsPieter E Oomen (0000-0001-8395-7331, Trimbos Institute), Dominique Schori (International Drug Development), Karsten Tögel-Lins (International Drug Development), Dean Acreman (International Drug Development), Sevag Chenorhokian (International Drug Development), Anton Luf (0000-0003-4013-7135, Medical University of Vienna), Alexandra Karden (0009-0002-1314-6124, International Drug Development), Carlos Paulos (International Drug Development), Elisa Fornero (International Drug Development), Enrico Gerace (0000-0002-4499-4276, Regione Campania), Raoul Pieter Joost Koning (0000-0003-1833-5696, International Drug Development), Liliana Galindo (0000-0002-2396-4772, Cambridgeshire and Peterborough NHS Foundation Trust), Laura A Smit-Rigter, Laura Smit‐Rigter (0000-0001-9767-1318, International Drug Development), Fiona Measham (0000-0002-9322-1931, International Drug Development), Mireia Ventura (0000-0003-1133-6872, International Drug Development, corresponding author)
Year2022
Volume100
Pages103493
Publication date2022-02-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueInternational Journal of Drug Policy (JOURNAL)
Journal identifiersISSN: 0955-3959 • E-ISSN: 1873-4758
PublisherElsevier BV (PUBLISHER)
DOI10.1016/j.drugpo.2021.103493
PMID34687992
OpenAlexW3210708675
LanguageEN
Citations received4
References cited10

Tools

Open DOI